Bell Investment Advisors’s Immunocore IMCR Stock Holding History

Bell Investment Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.25K	Buy	+134	New	+$3.96K	﹤0.01%	1044
2026 Q1	–	Sell	-39	Closed	-$1.35K	–	1901
2025 Q4	$1.35K	Hold	39	–	–	﹤0.01%	1474
2025 Q3	$1.42K	Hold	39	–	–	﹤0.01%	1450
2025 Q2	$1.22K	Buy	39 +25	+179%	+$777	﹤0.01%	1529
2025 Q1	$416	Hold	14	–	–	﹤0.01%	1811
2024 Q4	$413	Hold	14	–	–	﹤0.01%	1827
2024 Q3	$436	Sell	14 -13	-48%	-$473	﹤0.01%	1807
2024 Q2	$916	Buy	27 +9	+50%	+$459	﹤0.01%	1637
2024 Q1	$1.17K	Hold	18	–	–	﹤0.01%	1556
2023 Q4	$1.23K	Sell	18 -23	-56%	-$1.2K	﹤0.01%	1519
2023 Q3	$2.13K	Hold	41	–	–	﹤0.01%	1242
2023 Q2	$2.46K	Buy	+41	New	+$2.34K	﹤0.01%	1193

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bell Investment Advisors's IMCR Position: Q2 2026 in Review

Bell Investment Advisors opened a new position in Immunocore (IMCR) in Q2 2026: 134 shares worth $4.25K. The stake represents ﹤0.01% of the portfolio and ranks #1044 among its holdings. This is a return to the name: Bell Investment Advisors previously reported a position in IMCR as recently as Q4 2025.

Bell Investment Advisors first reported a position in IMCR in Q2 2023 and has held it in 12 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Bell Investment Advisors held 134 shares of Immunocore worth $4.25K as of Q2 2026.
Immunocore was a new Bell Investment Advisors position in Q2 2026.
Immunocore made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1044 holding.
Bell Investment Advisors first reported a position in Immunocore in Q2 2023 and has held it in 12 quarters since.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.